AU2003225944A1 - Modified release dosage forms with two cores and an opening - Google Patents

Modified release dosage forms with two cores and an opening

Info

Publication number: AU2003225944A1
Authority: AU; Australia
Prior art keywords: cores; opening; dosage forms; release dosage; modified release
Prior art date: 2002-09-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003225944A

Inventor

Gerard P. Mcnally

Harry S. Swoden

David Wynn

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Johnson and Johnson Consumer Inc

Original Assignee

McNeil PPC Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-09-28

Filing date

2003-03-21

Publication date

2004-04-19

2002-09-28 Priority claimed from PCT/US2002/031117 external-priority patent/WO2003026629A2/en

2003-03-21 Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc

2003-03-21 Priority claimed from PCT/US2003/008894 external-priority patent/WO2004028508A1/en

2004-04-19 Publication of AU2003225944A1 publication Critical patent/AU2003225944A1/en

Status Abandoned legal-status Critical Current

Links

AU2003225944A 2002-09-28 2003-03-21 Modified release dosage forms with two cores and an opening Abandoned AU2003225944A1 (en)

Applications Claiming Priority (11)

Application Number	Priority Date	Filing Date	Title
PCT/US2002/031117 WO2003026629A2 (en)	2001-09-28	2002-09-28	Modified release dosage forms
PCT/US2002/031062 WO2003026626A2 (en)	2001-09-28	2002-09-28	Modified release dosage forms
AUPCT/US2002/031129		2002-09-28
AU2002334741		2002-09-28
AUPCT/US2002/031024		2002-09-28
PCT/US2002/031163 WO2003026627A1 (en)	2001-09-28	2002-09-28	Composite dosage forms
PCT/US2002/031024 WO2003026625A1 (en)	2001-09-28	2002-09-28	Modified release dosage forms
AU2002334743		2002-09-28
AU2002347776		2002-09-28
PCT/US2002/031129 WO2003026630A1 (en)	2001-09-28	2002-09-28	Dosage forms having an inner core and outer shell with different shapes
PCT/US2003/008894 WO2004028508A1 (en)	2002-09-28	2003-03-21	Modified release dosage forms with two cores and an opening

Publications (1)

Publication Number	Publication Date
AU2003225944A1 true AU2003225944A1 (en)	2004-04-19

Family

ID=34271652

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
AU2003220466A Abandoned AU2003220466A1 (en)	2002-09-28	2003-03-21	Delayed release dosage forms
AU2003225944A Abandoned AU2003225944A1 (en)	2002-09-28	2003-03-21	Modified release dosage forms with two cores and an opening
AU2003220472A Abandoned AU2003220472A1 (en)	2002-09-28	2003-03-21	Modified release dosage form with two cores
AU2003218359A Abandoned AU2003218359A1 (en)	2002-09-28	2003-03-21	Polymer composition and dosage forms comprising the same

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU2003220466A Abandoned AU2003220466A1 (en)	2002-09-28	2003-03-21	Delayed release dosage forms

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
AU2003220472A Abandoned AU2003220472A1 (en)	2002-09-28	2003-03-21	Modified release dosage form with two cores
AU2003218359A Abandoned AU2003218359A1 (en)	2002-09-28	2003-03-21	Polymer composition and dosage forms comprising the same

Country Status (8)

Country	Link
JP (3)	JP2006517183A (en)
CN (3)	CN1700907A (en)
AT (1)	ATE444739T1 (en)
AU (4)	AU2003220466A1 (en)
BR (5)	BR0314777A (en)
CA (3)	CA2500313C (en)
DE (2)	DE60329614D1 (en)
MX (1)	MXPA05003283A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2470463C (en)	2004-06-09	2012-09-18	Lornamead Brands, Inc.	Tooth whitening products and methods of making the same
SA07280459B1 (en) *	2006-08-25	2011-07-20	بيورديو فارما إل. بي.	Tamper Resistant Oral Pharmaceutical Dosage Forms Comprising an Opioid Analgesic
EP2299986A1 (en) *	2008-06-19	2011-03-30	University Of The Witwatersrand, Johannesburg	A chronotherapeutic pharmaceutical dosage form
AU2011230778A1 (en) *	2010-03-23	2012-08-02	Aska Pharmaceutical Co., Ltd.	Solid preparation
US9693957B2 (en) *	2011-07-08	2017-07-04	The University Of North Carolina At Chapel Hill	Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
BR112014019526B8 (en) *	2012-02-07	2022-08-30	Chenango Zero Llc	RAPID RELEASE DOSAGE FORM AND ITS PRODUCTION METHOD
TW201400146A (en) *	2012-06-05	2014-01-01	Takeda Pharmaceutical	Core-containing tablet
EP3193845A1 (en) *	2014-09-19	2017-07-26	The Procter and Gamble Company	Pulsed release phenylephrine dosage forms
JP2021516697A (en) *	2017-12-29	2021-07-08	ラクソンメディカルアーゲーＬａｘｘｏｎＭｅｄｉｃａｌＡＧ	Drug delivery system
CN116801868A (en) *	2021-07-30	2023-09-22	埃维西亚治疗公司	Gastric retention dosage form of 5-hydroxytryptophan
CN115295864B (en) *	2021-11-09	2023-08-11	深圳市德方创域新能源科技有限公司	Positive electrode lithium supplementing additive and preparation method and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH07507564A (en) *	1992-09-30	1995-08-24	ファイザー・インク．	Articles containing a core and a coating of variable thickness
GB9402203D0 (en) *	1994-02-04	1994-03-30	Smithkline Beecham Plc	Pharmaceutical formulation
DE4431653C2 (en) *	1994-09-06	2000-01-20	Lohmann Therapie Syst Lts	Coated tablet for the controlled release of active substances, a process for their preparation and their use
IT1282576B1 (en) *	1996-02-06	1998-03-31	Jagotec Ag	PHARMACEUTICAL TABLET SUITABLE TO GIVE THE ACTIVE SUBSTANCE IN SUBSEQUENT AND PREDETERMINABLE TIMES
US6602521B1 (en) *	1998-09-29	2003-08-05	Impax Pharmaceuticals, Inc.	Multiplex drug delivery system suitable for oral administration
JPWO2001078681A1 (en) *	2000-04-17	2004-01-08	山之内製薬株式会社	Drug delivery system and method for avoiding pharmacokinetic drug interaction
DE60211130T2 (en) *	2001-02-13	2006-11-30	Astrazeneca Ab	NEW FORMULATION WITH MODIFIED RELEASE

2003
- 2003-03-21 CN CN03825324.0A patent/CN1700907A/en active Pending
- 2003-03-21 AU AU2003220466A patent/AU2003220466A1/en not_active Abandoned
- 2003-03-21 BR BR0314777-0A patent/BR0314777A/en not_active Application Discontinuation
- 2003-03-21 AU AU2003225944A patent/AU2003225944A1/en not_active Abandoned
- 2003-03-21 BR BR0314787-8A patent/BR0314787A/en not_active IP Right Cessation
- 2003-03-21 BR BR0314781-9A patent/BR0314781A/en not_active Application Discontinuation
- 2003-03-21 DE DE60329614T patent/DE60329614D1/en not_active Expired - Lifetime
- 2003-03-21 CN CN03823065.8A patent/CN1684671A/en active Pending
- 2003-03-21 CA CA2500313A patent/CA2500313C/en not_active Expired - Fee Related
- 2003-03-21 JP JP2004539770A patent/JP2006517183A/en active Pending
- 2003-03-21 AU AU2003220472A patent/AU2003220472A1/en not_active Abandoned
- 2003-03-21 CN CN03825331.3A patent/CN1700908A/en active Pending
- 2003-03-21 JP JP2004539769A patent/JP2006517182A/en active Pending
- 2003-03-21 BR BR0314547-6A patent/BR0314547A/en not_active Application Discontinuation
- 2003-03-21 MX MXPA05003283A patent/MXPA05003283A/en unknown
- 2003-03-21 BR BR0314804-1A patent/BR0314804A/en not_active Application Discontinuation
- 2003-03-21 CA CA002500311A patent/CA2500311A1/en not_active Abandoned
- 2003-03-21 DE DE60335270T patent/DE60335270D1/en not_active Expired - Lifetime
- 2003-03-21 JP JP2004539767A patent/JP2006517514A/en active Pending
- 2003-03-21 AU AU2003218359A patent/AU2003218359A1/en not_active Abandoned
- 2003-03-21 CA CA002500312A patent/CA2500312A1/en not_active Abandoned
- 2003-03-21 AT AT03714356T patent/ATE444739T1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
BR0314777A (en)	2005-07-26
DE60329614D1 (en)	2009-11-19
AU2003220466A1 (en)	2004-04-19
CN1700907A (en)	2005-11-23
CA2500313A1 (en)	2004-04-08
CA2500312A1 (en)	2004-04-08
JP2006517183A (en)	2006-07-20
CA2500313C (en)	2011-06-07
DE60335270D1 (en)	2011-01-20
BR0314787A (en)	2005-07-26
AU2003218359A1 (en)	2004-04-19
CN1684671A (en)	2005-10-19
ATE444739T1 (en)	2009-10-15
JP2006517514A (en)	2006-07-27
MXPA05003283A (en)	2005-11-23
BR0314804A (en)	2005-08-02
CN1700908A (en)	2005-11-23
JP2006517182A (en)	2006-07-20
AU2003220472A1 (en)	2004-04-19
CA2500311A1 (en)	2004-04-08
BR0314781A (en)	2005-07-26
BR0314547A (en)	2005-08-09

Legal Events

Date	Code	Title	Description
2005-06-16	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase

Publication	Publication Date	Title
AU2003266321A1 (en)	2004-04-08	Tetrahydropyrimidine-2-one derivatives and their uses
AU2003241478A1 (en)	2003-12-22	Nanoparticulate sterol formulations and sterol combinations
AU2003226094A1 (en)	2003-10-13	Compounds and methods
AU2003295572A1 (en)	2004-06-15	Value innovation management system and methods
AU2003250540A1 (en)	2004-02-25	Retarder and circular polarizer
AU2003239484A1 (en)	2003-12-22	Zooplankton enrichment with probionts and prebionts and uses thereof
AU2003267290A1 (en)	2004-04-08	Precast safety end and form therefor
AU2003296369A1 (en)	2004-06-30	Imminoamines and preparation thereof
AU2003273520A1 (en)	2004-04-08	Transformer and transformer unit having the same
AU2003225944A1 (en)	2004-04-19	Modified release dosage forms with two cores and an opening
AU2003215257A1 (en)	2003-09-09	Modified defensins and their use
AU2003207824A1 (en)	2003-10-20	K-type polarizer and preparation thereof
AU2003251766A1 (en)	2004-01-23	Partially ester-exchanged sipm and process therewith
AU2003268795A1 (en)	2004-04-19	Pallets and methods for manufacture and use thereof
AU2003298129A1 (en)	2004-06-15	Floor-furnace chimney and the use thereof
AU2003299943A1 (en)	2004-07-22	Heterocycles and uses thereof
AU2003283727A1 (en)	2004-07-14	Recording start and stop
AU2003212891A1 (en)	2003-10-20	K-type polarizer and preparation thereof
AU2003281691A1 (en)	2004-02-16	Furoisoquinoline derivative and use thereof
AU2003267361A1 (en)	2004-04-30	Orthopoxvirus antigens and use thereof
AU2003289369A1 (en)	2004-07-09	Message doll and message doll set
AU2003231827A1 (en)	2003-12-12	Pseudo-tissues and uses thereof
AU2003284942A1 (en)	2004-06-07	Oral extended release tablets and methods of making and using the same
AUPS167602A0 (en)	2002-05-16	An improved modified release preparation
AU2003256998A1 (en)	2004-02-16	Aperture forming means and package